Early treatment with ofatumumab increases the likelihood of stabilizing disease in patients with relapsing-remitting multiple sclerosis.

Stepień A, Pogoda-Wesołowska A, Staszewski J, Brola W, Kania K, Krzystanek E, Rusek S, Zajdel R, Hałas M, Karaszewski B

Arch Med Sci. 2026; 22(2):834-840. PMID: 42312094. Abstract